Biomedix (Gujarat) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.20 M
- Satisfied Charges ₹ 2.40 M
- Revenue Growth 41.21%
- Profit Growth -16.11%
- Ebitda 1659.84%
- Net Worth -88.43%
- Total Assets 4.72%
About Biomedix (Gujarat)
Biomedix (Gujarat) Pvt Ltd (BGPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 September 1995 and has a history of 29 years and four months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.20 M. The company has closed loans amounting to ₹2.40 M, as per Ministry of Corporate Affairs (MCA) records.
Alpavi Patel and Utpal Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ1995PTC027531
-
Company No.
027531
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Sep 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Biomedix (Gujarat)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alpavi Patel
|
Director | 21-Sep-1995 | Current |
|
Utpal Patel
|
Director | 21-Sep-1995 | Current |
Financial Performance of Biomedix (Gujarat).
Biomedix (Gujarat) Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 41.21% increase. The company also saw a substantial fall in profitability, with a 16.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 88.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomedix (Gujarat)?
In 2022, Biomedix (Gujarat) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.20 M
₹2.40 M
Charges Breakdown by Lending Institutions
- Hdb Financial Services Limited : 0.62 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2014 | Hdb Financial Services Limited | ₹6.20 M | Open |
| 03 Aug 2009 | Sardar Vallabhbhai Sahakari Bank Limited | ₹0.70 M | Satisfied |
| 06 Apr 2005 | Sardar Vallabhai Sahakari Bank Ltd. | ₹1.70 M | Satisfied |
How Many Employees Work at Biomedix (Gujarat)?
Unlock and access historical data on people associated with Biomedix (Gujarat), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomedix (Gujarat), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomedix (Gujarat)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.